![Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results 1 Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results](https://financialnewsarticles.com/wp-content/uploads/2022/04/lly-ceo-david-ricks-breaks-down-q1-earnings-obesity-drug-trial-results-SDAvbTejnnchqdefault.jpg)
Eli Lilly CEO David Ricks joins CNBC’s Meg Tirrell and the ‘Squawk Box’ team to break down the company’s latest earnings report and its clinical trial results for weight-loss drug tirzepatide.
Eli Lilly CEO David Ricks joins CNBC’s Meg Tirrell and the ‘Squawk Box’ team to break down the company’s latest earnings report and its clinical trial results for weight-loss drug tirzepatide.